TORNTPHARM / NSE / Biotechnology & Drugs
Torrent Pharmaceuticals
1Y Price Trend
Key Information
Recommendations
RatingBuy
Target High4,714.5
Target Low3,103
Target Mean2.14
Target Median42.24
Risk Metrics
Overall RiskModerate risk
Board Risk22.11
Key Analysis
Overall score, performance score, return rating, defensive, aggressive, and balanced views.
Download appProjection Analytics
Best-case, base-case, worst-case, and dynamic AI projection views.
Download appLatest stock news
Stocks to watch today: Hindalco, TVS Motor, Eicher Motors, NTPC, Lupin, Aurobindo Pharma, Torrent Pharmaceuticals, Colgate-Palmolive (India), Camlin Fine Sciences, Groww, Tata Capital, among other stocks are in focus today.
Shares to buy or sell: Chandan Taparia has recommended two stocks to buy today, 10 March 2026, and one stock to sell. Taparia recommends buying Torrent Pharmaceuticals and MCX shares today, while selling Maruti Suzuki stock futures.
Breakout stocks to buy or sell: Sumeet Bagadia recommends five shares to buy today — Torrent Pharmaceuticals, CCL Products (India), Schaeffler India, Jammu and Kashmir Bank, and Chennai Petroleum Corporation.
Torrent Pharma's share price jumped as much as 6% in the morning trade on Monday, February 16, to hit a record high of ₹ 4,322.80. Torrent Pharmaceuticals shares opened at ₹ 4,154.95 and jumped over 6% to an all-time high.
Torrent Pharma Q3 results: Profit jumped 26% YoY to ₹ 635 crore. Total revenue from operations for the December quarter stood at ₹ 3,303 crore, rising 17.6% YoY from ₹ 2,809 crore in Q3FY25.
As 2025 ends, Indian equity markets show cautious optimism. Despite volatility, select large-cap stocks like Tata Consumer, APL Apollo Tubes, Tech Mahindra, and Torrent Pharmaceuticals present strong technical setups for investors aiming for stability and growth into 2026.
Global private equity giant KKR is strategically planning a ‘dramatic’ increase in its India investments, aiming for the local market's activity to eventually mirror its global profile.
Torrent Pharma on Tuesday, 21 October 2025, received the CCI nod to acquire a majority stake in KKR-backed JB Chemicals through the ₹ 11,917 crore deal. Check deal details here…
© SharekeyX | Rusaka Technologies 2024-2026

